Wendy B.  London , PhD
  • Director of Biostatistics, Medicine, Children's Hospital Boston
  • Director, Clinical Translations Investigation Program, Pediatric Hematology/Oncology, Dana-Farber Cancer Institute
Office Phone: 617-632-4895
Appointment Line: 1-888-PEDI-ONC (733-4662)
Fax: 617-394-2949

Departments/Divisions

Specialties

biostatistics
clinical trials
neuroblastoma

Services/Programs

Academic Appointments

Associate Professor, Department of Medicine, Harvard Medical School

Language

English

Interests/Hobbies

Golf, Reading, Travel

Hometown

Washington, PA

College

Atmospheric Science/Mathematics, Purdue University, West Lafayette, IN  (May 1982)

Graduate School

Biostatistics, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA  (December 1997)

Professional Organizations

Member of the American Statistical Association, International Society for Pediatric Oncology, and American Society for Clinical Oncology

Awards

The 2006 Audrey Evans Prize for Outstanding Paper in Clinical Research, Advances in Neuroblastoma Research Association

Publications

George R.E., Sanda T., Hanna M., Frohling S., Luther II W., Zhang J., Zozulya S., London W.B., Gregor V., McGrady P., Gray N.S., Webb T.R., Xue L., Gilliland D.G., Greulich H., Morris S.W., Meyerson M., Look A.T.
Inhibitor-sensitive mutations in the ALK receptor tyrosine kinase provide a therapeutic target in neuroblastoma. , October 16, 2008
Nature  Issue: 455(7215) , Page: 975-978
Cohn S.L.*, Pearson A.D.J.*, London W.B., Monclair T., Ambros P.F., Faldum A., Hero B., Iehara T., Machin D., Mosseri V., Matthay K.K., for the INRG Task Force
The International Neuroblastoma Risk Group (INRG) classification system. , January 10, 2009
Journal of Clinical Oncology  Issue: 27(2) , Page: 289-97
Sposto R., London W.B., Alonzo T.A.
Criteria for optimizing prognostic risk groups in pediatric cancer: Analysis of data from the Children's Oncology Group. , May 20, 2007
Journal of Clinical Oncology  Issue: 25(15) , Page: 2070-2077
Attiyeh E.F., London W.B., Mosse Y.P., Wang Q., Winter C., Khazi D., McGrady P., Seeger R.C., Look A.T., Shimada H., Brodeur G.M., Cohn S.L., Matthay K.K., Maris J.M.
Chromosome 11q deletion is an independent marker for decreased survival probability in patients with neuroblastoma: A Childrens Oncology Group study. , November 24, 2005
New England Journal of Medicine  Issue: 353(21) , Page: 2243-2253
London W.B., Castleberry R.P., Matthay K.K., Look A.T., Seeger B., Shimada H., Thorner P., Brodeur G., Maris J.M., Reynolds C.P., Cohn S.L.
Evidence for an age cut-off greater than 365 days for neuroblastoma risk group stratification in the Childrens Oncology Group. , September 20, 2005
Journal of Clinical Oncology  Issue: 23(27) , Page: 6459-6465
Hunsberger S., Albert P., London W.B.
. A finite mixture survival model to characterize risk groups of neuroblastoma. , April 15, 2009
Statistics in Medicine  Issue: 28(8) , Page: 1301-14
Tebbi D.K., London W.B., Friedman D., Doojduen D.V., deAlarcon P., Constine L.S., Mendenhall N., Sposto R., Chauvenet A., Schwartz C.L.
Dexrazoxane associated risk of secondary malignancy in pediatric Hodgkin disease. , February 10, 2007
Journal of Clinical Oncology  Issue: 25 , Page: 493-500
London W.B., Chang M.N.
One- and two-stage designs for stratified Phase II clinical trials. , 2005
Statistics in Medicine  Issue: 24(17) , Page: 2597-2611
George R.E., London W.B., Cohn S.L., Maris J.M., Kretschmar C., Diller L., Brodeur G.M., Castleberry R.P., Look A.T.
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. , September 20, 2005
Journal of Clinical Oncology  Issue: 23(27) , Page: 6466-6473
Lead Statistician for Neuroblastoma research, Childrens Oncology Group Statistics and Data Center Statistics Committee Chair, International Neuroblastoma Risk Group project

  • Dana-Farber/Children's Hospital Cancer Center
    Hematology/Oncology
    450 Brookline Avenue
    SW G300B
    Boston, MA  02215
    Phone: 617-632-4895
    Fax: 617-394-2949
schedule an appointment
Our Print on Demand feature allows you to print a specialist directory by specialty.